Central Nervous System Smooth Muscle Tumor Linked to Epstein-Barr Virus in an HIV-Infected Individual: Challenges in Diagnosis and Treatment
By
Imad Majeed
Kenneth Schott Hannan
Aeron Buckley
Zaraq Rashid Khan
Faisal Rasheed
Lama Hanbali
Eyas M. Hattab
February 4, 2026
Clinical Scorecard: Central Nervous System Smooth Muscle Tumor Linked to Epstein-Barr Virus in an HIV-Infected Individual: Challenges in Diagnosis and Treatment
At a Glance
Category Detail
Condition Epstein-Barr virus-associated smooth muscle tumor (EBV-SMT) Key Mechanisms Associated with Epstein-Barr virus (EBV) in immunocompromised patients, particularly those with HIV. Target Population HIV-positive individuals, particularly those with low CD4 counts. Care Setting Hospital emergency department and neurosurgery unit.
Key Highlights
EBV-SMT is a rare spindle cell tumor primarily affecting immunocompromised patients. Diagnosis involves immunohistochemistry and PCR testing for EBV. Management includes surgical intervention and antiretroviral therapy adjustments. Guideline-Based Recommendations
Diagnosis
Identify smooth muscle markers using immunohistochemistry. Detect EBV-encoded small RNAs (EBERs) or EBV DNA through PCR testing. Management
Symptomatic management with analgesics and seizure prophylaxis. Surgical resection of tumors when indicated. Monitoring & Follow-up
Regular monitoring of CD4 counts and viral load in HIV patients. Post-operative imaging to assess for residual disease. Risks
Increased risk of complications due to immunocompromised state. Potential for misdiagnosis as other tumors such as meningiomas. Patient & Prescribing Data
HIV-positive individuals with low CD4 counts.
Adjust antiretroviral therapy based on resistance testing and clinical response.
Clinical Best Practices
Consult infectious disease specialists for optimal ART management. Consider multidisciplinary approaches for complex cases involving neurosurgery and oncology. References
